Numida meleagris isolate 19003 breed g44 Domestic line chromosome 16, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007829.1.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
dual specificity testis-specific protein kinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like isoform X2
dual specificity testis-specific protein kinase 1-like isoform X1
dual specificity testis-specific protein kinase 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
kelch-like protein 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
kelch-like protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
kelch-like protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
mannosidase alpha class 1B member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
mannosidase alpha class 1B member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase isoform X2
endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
UDP-N-acetylhexosamine pyrophosphorylase-like protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: suppressor APC domain-containing protein 2
ectonucleoside triphosphate diphosphohydrolase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transmembrane protein 141, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
transmembrane protein 141, transcript variant X2
transmembrane protein 141, transcript variant X1
transmembrane protein 141, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transmembrane protein 141, transcript variant X5
transmembrane protein 141, transcript variant X4
chromosome 16 C9orf142 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 16 C9orf142 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 16 C9orf142 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
chromosome 16 C9orf142 homolog, transcript variant X2
chromosome 16 C9orf142 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
chloride intracellular channel protein 3
ATP binding cassette subfamily A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ATP-binding cassette sub-family A member 2
fucosyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
fucosyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 7 isoform X1
alpha-(1,3)-fucosyltransferase 7 isoform X2
POU domain, class 5, transcription factor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
neural proliferation, differentiation and control 1
similar to RNA sequence (same species):INSD:GBYG01006841.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 122 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 82 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
neural proliferation differentiation and control protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
extracellular fatty acid-binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
extracellular fatty acid-binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
extracellular fatty acid-binding protein isoform X2
extracellular fatty acid-binding protein isoform X1
complement C8 gamma chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
complement C8 gamma chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
complement C8 gamma chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
complement component C8 gamma chain isoform X2
complement component C8 gamma chain isoform X3
complement component C8 gamma chain isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
TNF receptor-associated factor 2 isoform X3
TNF receptor-associated factor 2 isoform X1
TNF receptor-associated factor 2 isoform X2
endothelial differentiation related factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
endothelial differentiation-related factor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: apical endosomal glycoprotein
phosphohistidine phosphatase 1, transcript variant X3
phosphohistidine phosphatase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
phosphohistidine phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
14 kDa phosphohistidine phosphatase isoform X3
14 kDa phosphohistidine phosphatase isoform X2
14 kDa phosphohistidine phosphatase isoform X1
phosphohistidine phosphatase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
14 kDa phosphohistidine phosphatase isoform X4
chromosome 16 C9orf172 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome 16 C9orf172 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 16 C9orf172 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C9orf172 homolog
RAB, member RAS oncogene family like 6, transcript variant X2
RAB, member RAS oncogene family like 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
notch-regulated ankyrin repeat-containing protein
exonuclease 3'-5' domain containing 3, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
exonuclease 3'-5' domain containing 3, transcript variant X15
exonuclease 3'-5' domain containing 3, transcript variant X3
exonuclease 3'-5' domain containing 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X8
exonuclease 3'-5' domain containing 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X5
exonuclease 3'-5' domain containing 3, transcript variant X9
exonuclease 3'-5' domain containing 3, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X2
exonuclease 3'-5' domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
exonuclease 3'-5' domain containing 3, transcript variant X13
exonuclease 3'-5' domain containing 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NADPH oxidase activator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
NADPH oxidase activator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8 isoform X1
ectonucleoside triphosphate diphosphohydrolase 8 isoform X3
ectonucleoside triphosphate diphosphohydrolase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8 isoform X2
ectonucleoside triphosphate diphosphohydrolase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8 isoform X4
ectonucleoside triphosphate diphosphohydrolase 8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 8-like isoform X2
ectonucleoside triphosphate diphosphohydrolase 8-like isoform X1
ectonucleoside triphosphate diphosphohydrolase 8-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
NADPH dependent diflavin oxidoreductase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
NADPH dependent diflavin oxidoreductase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
NADPH dependent diflavin oxidoreductase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
NADPH dependent diflavin oxidoreductase 1, transcript variant X4
NADPH dependent diflavin oxidoreductase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
NADPH-dependent diflavin oxidoreductase 1 isoform X1
NADPH-dependent diflavin oxidoreductase 1 isoform X3
NADPH-dependent diflavin oxidoreductase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat-containing protein 26
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X13
glutamate receptor ionotropic, NMDA 1 isoform X10
glutamate receptor ionotropic, NMDA 1 isoform X11
glutamate receptor ionotropic, NMDA 1 isoform X9
glutamate receptor ionotropic, NMDA 1 isoform X5
glutamate receptor ionotropic, NMDA 1 isoform X3
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X1
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X8
glutamate receptor ionotropic, NMDA 1 isoform X6
glutamate receptor ionotropic, NMDA 1 isoform X1
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 1, transcript variant X4
glutamate receptor ionotropic, NMDA 1 isoform X7
glutamate receptor ionotropic, NMDA 1 isoform X2
glutamate receptor ionotropic, NMDA 1 isoform X4
glutamate receptor ionotropic, NMDA 1 isoform X12
zinc finger protein 618, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 618, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 618, transcript variant X6
zinc finger protein 618, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 618, transcript variant X1
zinc finger protein 618, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 618, transcript variant X13
zinc finger protein 618, transcript variant X14
zinc finger protein 618, transcript variant X7
zinc finger protein 618, transcript variant X8
zinc finger protein 618, transcript variant X9
zinc finger protein 618, transcript variant X4
zinc finger protein 618, transcript variant X2
zinc finger protein 618, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 618, transcript variant X15
zinc finger protein 618, transcript variant X11
zinc finger protein 618, transcript variant X10
zinc finger protein 618, transcript variant X18
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC110406773, transcript variant X2
uncharacterized LOC110406773, transcript variant X1
regulator of G protein signaling 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
regulator of G protein signaling 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
regulator of G-protein signaling 3 isoform X1
regulator of G-protein signaling 3 isoform X3
regulator of G-protein signaling 3 isoform X2
regulator of G-protein signaling 3 isoform X4
regulator of G-protein signaling 3 isoform X5
regulator of G-protein signaling 3 isoform X7
regulator of G-protein signaling 3 isoform X6
DNA polymerase epsilon 3, accessory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
aminolevulinate dehydratase, transcript variant X1
aminolevulinate dehydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
delta-aminolevulinic acid dehydratase isoform X2
delta-aminolevulinic acid dehydratase isoform X1
haloacid dehalogenase like hydrolase domain containing 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
haloacid dehalogenase-like hydrolase domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
B box and SPRY domain-containing protein
WD repeat domain 31, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WD repeat domain 31, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
WD repeat domain 31, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
WD repeat domain 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
WD repeat domain 31, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WD repeat domain 31, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
WD repeat-containing protein 31 isoform X3
WD repeat-containing protein 31 isoform X1
WD repeat-containing protein 31 isoform X2
WD repeat-containing protein 31 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
U4/U6 small nuclear ribonucleoprotein Prp4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
anaphase-promoting complex subunit CDC26
solute carrier family 31 member 1, transcript variant X2
solute carrier family 31 member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 31 member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 31 member 1, transcript variant X4
solute carrier family 31 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
FK506 binding protein 15, transcript variant X1
FK506 binding protein 15, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
FK506 binding protein 15, transcript variant X2
FK506 binding protein 15, transcript variant X3
FK506 binding protein 15, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
FK506 binding protein 15, transcript variant X6
FK506 binding protein 15, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leucine rich repeat and sterile alpha motif containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
leucine rich repeat and sterile alpha motif containing 1, transcript variant X1
leucine rich repeat and sterile alpha motif containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
leucine rich repeat and sterile alpha motif containing 1, transcript variant X4
leucine rich repeat and sterile alpha motif containing 1, transcript variant X2
leucine rich repeat and sterile alpha motif containing 1, transcript variant X6
E3 ubiquitin-protein ligase LRSAM1 isoform X5
E3 ubiquitin-protein ligase LRSAM1 isoform X1
E3 ubiquitin-protein ligase LRSAM1 isoform X3
E3 ubiquitin-protein ligase LRSAM1 isoform X4
E3 ubiquitin-protein ligase LRSAM1 isoform X2
E3 ubiquitin-protein ligase LRSAM1 isoform X6
leucine rich repeat and sterile alpha motif containing 1, transcript variant X7
E3 ubiquitin-protein ligase LRSAM1 isoform X7
sperm-tail PG-rich repeat containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm-tail PG-rich repeat containing 3, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01031001.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 153 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 51 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
zinc finger MYND domain-containing protein 19
diphthamide biosynthesis 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
diphthamide biosynthesis 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L41, mitochondrial
patatin like phospholipase domain containing 7, transcript variant X1
patatin like phospholipase domain containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
patatin like phospholipase domain containing 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
patatin-like phospholipase domain-containing protein 7
NMDA receptor synaptonuclear signaling and neuronal migration factor, transcript variant X1
NMDA receptor synaptonuclear signaling and neuronal migration factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
NMDA receptor synaptonuclear signaling and neuronal migration factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NMDA receptor synaptonuclear signaling and neuronal migration factor isoform X1
NMDA receptor synaptonuclear signaling and neuronal migration factor isoform X2
NMDA receptor synaptonuclear signaling and neuronal migration factor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
SS nuclear autoantigen 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Sjoegren syndrome nuclear autoantigen 1 isoform X2
SS nuclear autoantigen 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Sjoegren syndrome nuclear autoantigen 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
discoidin domain-containing receptor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
discoidin domain-containing receptor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
discoidin domain-containing receptor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
discoidin domain-containing receptor 2-like isoform X1
discoidin domain-containing receptor 2-like isoform X2
family with sequence similarity 166 member A, transcript variant X2
family with sequence similarity 166 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 208 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110407008, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110407008, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2-like isoform X1
ectonucleoside triphosphate diphosphohydrolase 2-like, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 2-like isoform X2
negative elongation factor complex member B
tumor necrosis factor ligand superfamily member 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC110407007 isoform X1
tumor necrosis factor ligand superfamily member 6-like isoform X2
glutamine synthetase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glutamine synthetase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamine synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamine synthetase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamine synthetase, transcript variant X2
glutamine synthetase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
arrestin domain containing 1, transcript variant X1
arrestin domain-containing protein 1 isoform X1
arrestin domain containing 1, transcript variant X2
arrestin domain-containing protein 1 isoform X2
euchromatic histone lysine methyltransferase 1, transcript variant X6
histone-lysine N-methyltransferase EHMT1 isoform X6
euchromatic histone lysine methyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1 isoform X7
euchromatic histone lysine methyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1 isoform X8
euchromatic histone lysine methyltransferase 1, transcript variant X9
histone-lysine N-methyltransferase EHMT1 isoform X9
euchromatic histone lysine methyltransferase 1, transcript variant X13
euchromatic histone lysine methyltransferase 1, transcript variant X14
euchromatic histone lysine methyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
euchromatic histone lysine methyltransferase 1, transcript variant X3
euchromatic histone lysine methyltransferase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
euchromatic histone lysine methyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
euchromatic histone lysine methyltransferase 1, transcript variant X4
histone-lysine N-methyltransferase EHMT1 isoform X1
histone-lysine N-methyltransferase EHMT1 isoform X3
histone-lysine N-methyltransferase EHMT1 isoform X5
histone-lysine N-methyltransferase EHMT1 isoform X2
histone-lysine N-methyltransferase EHMT1 isoform X4
euchromatic histone lysine methyltransferase 1, transcript variant X12
histone-lysine N-methyltransferase EHMT1 isoform X12
euchromatic histone lysine methyltransferase 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
euchromatic histone lysine methyltransferase 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1 isoform X10
histone-lysine N-methyltransferase EHMT1 isoform X11
histone-lysine N-methyltransferase EHMT1 isoform X13
euchromatic histone lysine methyltransferase 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1 isoform X14
calcium voltage-gated channel subunit alpha1 B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent N-type calcium channel subunit alpha-1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
probable low affinity copper uptake protein 2
family with sequence similarity 129 member B
similar to RNA sequence (same species):INSD:GBYG01017316.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 70 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 55 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01015053.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 205 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 37 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 268, transcript variant X2
transmembrane protein 268, transcript variant X4
transmembrane protein 268, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 268, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC110407056, transcript variant X1
uncharacterized LOC110407056, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110407058, transcript variant X2
uncharacterized LOC110407058, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X8
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X5
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X7
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X6
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like, transcript variant X9
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110406925, transcript variant X1
uncharacterized LOC110406925, transcript variant X2
uncharacterized LOC110406925, transcript variant X3
uncharacterized LOC110406925, transcript variant X6
uncharacterized LOC110406925, transcript variant X4
uncharacterized LOC110406925, transcript variant X5
BMP/retinoic acid inducible neural specific 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BMP/retinoic acid-inducible neural-specific protein 1
uncharacterized LOC110406934, transcript variant X2
uncharacterized LOC110406934, transcript variant X1
uncharacterized LOC110407110, transcript variant X1
uncharacterized LOC110407110, transcript variant X2
uncharacterized LOC110407110, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit-associated protein 2 isoform X2
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 9
collagen type XXVII alpha 1 chain, transcript variant X2
collagen type XXVII alpha 1 chain, transcript variant X1
collagen alpha-1(XXVII) chain isoform X1
collagen alpha-1(XXVII) chain isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-1-acid glycoprotein 1-like
solute carrier family 25 member 25, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 25 member 25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 25 member 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X2
nuclear apoptosis inducing factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nuclear apoptosis inducing factor 1, transcript variant X1
family with sequence similarity 102 member A
dolichyl-phosphate mannosyltransferase subunit 2, regulatory
dolichol phosphate-mannose biosynthesis regulatory protein
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
adenylate kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
adenylate kinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenylate kinase 1, transcript variant X2
folylpolyglutamate synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
folylpolyglutamate synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
folylpolyglutamate synthase, mitochondrial isoform X2
folylpolyglutamate synthase, mitochondrial isoform X1
SH2 domain containing 3C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SH2 domain-containing protein 3C isoform X1
SH2 domain containing 3C, transcript variant X2
SH2 domain-containing protein 3C isoform X2
SH2 domain containing 3C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
SH2 domain-containing protein 3C isoform X3
torsin family 2 member A, transcript variant X3
torsin family 2 member A, transcript variant X2
torsin family 2 member A, transcript variant X1
tetratricopeptide repeat domain 16, transcript variant X1
tetratricopeptide repeat domain 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tetratricopeptide repeat domain 16, transcript variant X2
tetratricopeptide repeat domain 16, transcript variant X4
tetratricopeptide repeat domain 16, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
tetratricopeptide repeat protein 16 isoform X3
tetratricopeptide repeat protein 16 isoform X2
tetratricopeptide repeat protein 16 isoform X1
tetratricopeptide repeat protein 16 isoform X5
tetratricopeptide repeat protein 16 isoform X4
cerebral endothelial cell adhesion molecule, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
probable inactive glycosyltransferase 25 family member 3 isoform X1
probable inactive glycosyltransferase 25 family member 3 isoform X2
ubiquitin related modifier 1, transcript variant X1
ubiquitin related modifier 1, transcript variant X2
long-chain fatty acid transport protein 4
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X1
TruB pseudouridine synthase family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
SWI5 homologous recombination repair protein, transcript variant X2
SWI5 homologous recombination repair protein, transcript variant X1
DNA repair protein SWI5 homolog isoform X2
DNA repair protein SWI5 homolog isoform X1
SWI5 homologous recombination repair protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC110407067, transcript variant X1
uncharacterized LOC110407067, transcript variant X2
CDKN1A interacting zinc finger protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X2
outer dense fiber of sperm tails 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X3
outer dense fiber of sperm tails 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X5
spectrin alpha, non-erythrocytic 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X3
spectrin alpha, non-erythrocytic 1, transcript variant X4
spectrin alpha, non-erythrocytic 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
spectrin alpha chain, non-erythrocytic 1 isoform X5
spectrin alpha chain, non-erythrocytic 1 isoform X2
spectrin alpha chain, non-erythrocytic 1 isoform X1
spectrin alpha chain, non-erythrocytic 1 isoform X3
spectrin alpha chain, non-erythrocytic 1 isoform X4
spectrin alpha chain, non-erythrocytic 1 isoform X6
spectrin alpha chain, non-erythrocytic 1 isoform X7
spectrin alpha chain, non-erythrocytic 1 isoform X8
SET nuclear proto-oncogene, transcript variant X1
SET nuclear proto-oncogene, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
protein kinase N3, transcript variant X1
protein kinase N3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein kinase N3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase N3 isoform X1
serine/threonine-protein kinase N3 isoform X2
serine/threonine-protein kinase N3 isoform X3
uncharacterized LOC110407098, transcript variant X2
uncharacterized LOC110407098, transcript variant X6
uncharacterized LOC110407098, transcript variant X1
uncharacterized LOC110407098, transcript variant X3
uncharacterized LOC110407098, transcript variant X4
uncharacterized LOC110407098, transcript variant X5
uncharacterized LOC110407098, transcript variant X7
SPOUT domain containing methyltransferase 1
putative methyltransferase C9orf114 homolog
kynurenine aminotransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
kynurenine aminotransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
kynurenine aminotransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
kynurenine aminotransferase 1, transcript variant X4
kynurenine--oxoglutarate transaminase 1 isoform X1
kynurenine--oxoglutarate transaminase 1 isoform X2
kynurenine--oxoglutarate transaminase 1 isoform X3
leucine rich repeat containing 8 family member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leucine rich repeat containing 8 family member A, transcript variant X1
leucine rich repeat containing 8 family member A, transcript variant X6
leucine rich repeat containing 8 family member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
leucine rich repeat containing 8 family member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
leucine rich repeat containing 8 family member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8A
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X1
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X1
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X2
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
SH3 domain containing GRB2 like, endophilin B2, transcript variant X5
SH3 domain containing GRB2 like, endophilin B2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SH3 domain containing GRB2 like, endophilin B2, transcript variant X2
SH3 domain containing GRB2 like, endophilin B2, transcript variant X3
SH3 domain containing GRB2 like, endophilin B2, transcript variant X4
SH3 domain containing GRB2 like, endophilin B2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dolichyldiphosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
dolichyldiphosphatase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
LOW QUALITY PROTEIN: carnitine O-acetyltransferase
protein phosphatase 2 phosphatase activator, transcript variant X1
protein phosphatase 2 phosphatase activator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A activator isoform X1
protein phosphatase 2 phosphatase activator, transcript variant X3
serine/threonine-protein phosphatase 2A activator isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
immediate early response gene 5-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC110406801, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110406801, transcript variant X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X5
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X4
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X6
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X7
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1
ankyrin repeat and SOCS box containing 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
paired related homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
paired related homeobox 2, transcript variant X2
paired mesoderm homeobox protein 2 isoform X1
paired mesoderm homeobox protein 2 isoform X2
prostaglandin E synthase, transcript variant X1
prostaglandin E synthase, transcript variant X7
prostaglandin E synthase, transcript variant X2
prostaglandin E synthase, transcript variant X5
prostaglandin E synthase, transcript variant X4
prostaglandin E synthase, transcript variant X3
prostaglandin E synthase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 16 C9orf78 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 16 C9orf78 homolog, transcript variant X2
uncharacterized protein C9orf78 homolog isoform X1
uncharacterized protein C9orf78 homolog isoform X2
ubiquitin specific peptidase 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X1
ubiquitin specific peptidase 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 20 isoform X1
ubiquitin carboxyl-terminal hydrolase 20 isoform X2
formin binding protein 1, transcript variant X5
formin binding protein 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
formin binding protein 1, transcript variant X11
formin binding protein 1, transcript variant X6
formin binding protein 1, transcript variant X1
formin binding protein 1, transcript variant X7
formin binding protein 1, transcript variant X3
formin binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
formin binding protein 1, transcript variant X8
formin binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
formin binding protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
formin binding protein 1, transcript variant X10
G protein-coupled receptor 107, transcript variant X1
G protein-coupled receptor 107, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
far upstream element binding protein 3, transcript variant X1
far upstream element binding protein 3, transcript variant X2
far upstream element binding protein 3, transcript variant X4
far upstream element binding protein 3, transcript variant X9
far upstream element binding protein 3, transcript variant X5
far upstream element binding protein 3, transcript variant X3
far upstream element binding protein 3, transcript variant X8
far upstream element binding protein 3, transcript variant X7
far upstream element binding protein 3, transcript variant X6
far upstream element binding protein 3, transcript variant X10
far upstream element-binding protein 3 isoform X1
far upstream element-binding protein 3 isoform X6
far upstream element-binding protein 3 isoform X5
far upstream element-binding protein 3 isoform X8
far upstream element-binding protein 3 isoform X2
far upstream element-binding protein 3 isoform X3
far upstream element-binding protein 3 isoform X7
far upstream element-binding protein 3 isoform X4
far upstream element binding protein 3, transcript variant X11
far upstream element-binding protein 3 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibrinogen C domain-containing protein 1
laminin subunit gamma 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
laminin subunit gamma 3, transcript variant X2
nuclear pore complex protein Nup214 isoform X1
nuclear pore complex protein Nup214 isoform X2
nuclear pore complex protein Nup214 isoform X4
nuclear pore complex protein Nup214 isoform X3
family with sequence similarity 78 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
family with sequence similarity 78 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
proline rich coiled-coil 2B, transcript variant X9
proline rich coiled-coil 2B, transcript variant X10
proline rich coiled-coil 2B, transcript variant X4
proline rich coiled-coil 2B, transcript variant X3
proline rich coiled-coil 2B, transcript variant X1
proline rich coiled-coil 2B, transcript variant X7
proline rich coiled-coil 2B, transcript variant X5
proline rich coiled-coil 2B, transcript variant X8
proline rich coiled-coil 2B, transcript variant X6
proline rich coiled-coil 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
proline-rich transmembrane protein 1, transcript variant X1
proline-rich transmembrane protein 1, transcript variant X3
proline-rich transmembrane protein 1, transcript variant X2
Rap guanine nucleotide exchange factor 1, transcript variant X5
Rap guanine nucleotide exchange factor 1, transcript variant X1
Rap guanine nucleotide exchange factor 1, transcript variant X2
Rap guanine nucleotide exchange factor 1, transcript variant X3
Rap guanine nucleotide exchange factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rap guanine nucleotide exchange factor 1 isoform X4
rap guanine nucleotide exchange factor 1 isoform X1
rap guanine nucleotide exchange factor 1 isoform X2
rap guanine nucleotide exchange factor 1 isoform X3
uncharacterized LOC110406915, transcript variant X1
uncharacterized LOC110406915, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
cilia and flagella associated protein 77, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cilia and flagella associated protein 77, transcript variant X9
cilia and flagella associated protein 77, transcript variant X6
cilia and flagella associated protein 77, transcript variant X8
cilia and flagella associated protein 77, transcript variant X1
cilia and flagella associated protein 77, transcript variant X4
cilia and flagella associated protein 77, transcript variant X5
cilia and flagella associated protein 77, transcript variant X10
cilia- and flagella-associated protein 77 isoform X2
cilia- and flagella-associated protein 77 isoform X9
cilia- and flagella-associated protein 77 isoform X6
cilia- and flagella-associated protein 77 isoform X4
cilia- and flagella-associated protein 77 isoform X1
cilia- and flagella-associated protein 77 isoform X5
cilia- and flagella-associated protein 77 isoform X8
cilia and flagella associated protein 77, transcript variant X7
cilia- and flagella-associated protein 77 isoform X7
cilia and flagella associated protein 77, transcript variant X3
cilia- and flagella-associated protein 77 isoform X3
cilia- and flagella-associated protein 77 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
DEAD-box helicase 31, transcript variant X2
DEAD-box helicase 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX31 isoform X2
probable ATP-dependent RNA helicase DDX31 isoform X1
uncharacterized LOC110406751, transcript variant X1
uncharacterized LOC110406751, transcript variant X3
uncharacterized LOC110406751, transcript variant X2
general transcription factor IIIC subunit 4, transcript variant X5
general transcription factor IIIC subunit 4, transcript variant X6
general transcription factor IIIC subunit 4, transcript variant X1
general transcription factor IIIC subunit 4, transcript variant X4
general transcription factor IIIC subunit 4, transcript variant X3
general transcription factor IIIC subunit 4, transcript variant X2
general transcription factor 3C polypeptide 4
adenylate kinase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
adenylate kinase 8, transcript variant X2
adenylate kinase 8, transcript variant X1
adenylate kinase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
adenylate kinase 8, transcript variant X5
sperm acrosome associated 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
sperm acrosome associated 9, transcript variant X1
sperm acrosome associated 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
sperm acrosome-associated protein 9 isoform X2
sperm acrosome-associated protein 9 isoform X1
tuberous sclerosis 1, transcript variant X6
tuberous sclerosis 1, transcript variant X5
tuberous sclerosis 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
tuberous sclerosis 1, transcript variant X2
tuberous sclerosis 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
tuberous sclerosis 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
tuberous sclerosis 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
growth factor independent 1B transcriptional repressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth factor independent 1B transcriptional repressor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
growth factor independent 1B transcriptional repressor, transcript variant X3
similar to RNA sequence (same species):INSD:GBYG01011432.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 154 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 66 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 154 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
general transcription factor IIIC subunit 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
general transcription factor IIIC subunit 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
general transcription factor 3C polypeptide 5 isoform X1
general transcription factor 3C polypeptide 5 isoform X2
ral guanine nucleotide dissociation stimulator
similar to RNA sequence (same species):INSD:GBYG01013000.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 251 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 251 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, transcript variant X2
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform X2
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform X1
coiled-coil domain containing 180, transcript variant X2
coiled-coil domain containing 180, transcript variant X3
coiled-coil domain containing 180, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coiled-coil domain containing 180, transcript variant X4
coiled-coil domain-containing protein 180 isoform X2
coiled-coil domain-containing protein 180 isoform X3
coiled-coil domain-containing protein 180 isoform X4
coiled-coil domain-containing protein 180 isoform X1
coiled-coil domain containing 180, transcript variant X5
coiled-coil domain-containing protein 180 isoform X5
coiled-coil domain containing 180, transcript variant X6
coiled-coil domain-containing protein 180 isoform X6
mediator complex subunit 22, transcript variant X2
mediator complex subunit 22, transcript variant X1
mediator of RNA polymerase II transcription subunit 22 isoform X2
mediator of RNA polymerase II transcription subunit 22 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/threonine kinase like domain containing 1, transcript variant X3
serine/threonine kinase like domain containing 1, transcript variant X4
serine/threonine kinase like domain containing 1, transcript variant X5
serine/threonine kinase like domain containing 1, transcript variant X2
serine/threonine kinase like domain containing 1, transcript variant X1
serine/threonine kinase-like domain-containing protein STKLD1 isoform X1
serine/threonine kinase-like domain-containing protein STKLD1 isoform X2
serine/threonine kinase-like domain-containing protein STKLD1 isoform X3
serine/threonine kinase like domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
serine/threonine kinase-like domain-containing protein STKLD1 isoform X4
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X6
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X7
ADAM metallopeptidase with thrombospondin type 1 motif 13, transcript variant X5
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X4
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X6
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X7
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X5
calcium channel flower domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
family with sequence similarity 163 member B
dopamine beta-hydroxylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
dopamine beta-hydroxylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
vav guanine nucleotide exchange factor 2, transcript variant X2
vav guanine nucleotide exchange factor 2, transcript variant X1
guanine nucleotide exchange factor VAV2 isoform X1
guanine nucleotide exchange factor VAV2 isoform X2
bromodomain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bromodomain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bromodomain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ly6/PLAUR domain-containing protein 1-like, transcript variant X1
ly6/PLAUR domain-containing protein 1-like
ly6/PLAUR domain-containing protein 1-like, transcript variant X2
uncharacterized LOC110406981, transcript variant X3
uncharacterized LOC110406981, transcript variant X1
uncharacterized LOC110406981, transcript variant X2
uncharacterized LOC110406788, transcript variant X2
uncharacterized LOC110406788, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC110406938, transcript variant X1
uncharacterized LOC110406938, transcript variant X2
collagen type V alpha 1 chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
collagen type V alpha 1 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
collagen type V alpha 1 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC110407018, transcript variant X2
uncharacterized LOC110407018, transcript variant X3
uncharacterized LOC110407018, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC110406730, transcript variant X1
uncharacterized LOC110406730, transcript variant X2
family with sequence similarity 69 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
1-acylglycerol-3-phosphate O-acyltransferase 2
1-acyl-sn-glycerol-3-phosphate acyltransferase beta
EGF like domain multiple 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
EGF like domain multiple 7, transcript variant X3
EGF like domain multiple 7, transcript variant X2
EGF like domain multiple 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
EGF like domain multiple 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
epidermal growth factor-like protein 7 isoform X1
epidermal growth factor-like protein 7 isoform X2
neurogenic locus notch homolog protein 1 isoform X1
neurogenic locus notch homolog protein 1 isoform X2
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X4
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X1
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X3
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X5
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X2
protein transport protein Sec16A isoform X1
protein transport protein Sec16A isoform X3
protein transport protein Sec16A isoform X2
protein transport protein Sec16A isoform X4
protein transport protein Sec16A isoform X5
inositol polyphosphate-5-phosphatase E, transcript variant X1
inositol polyphosphate-5-phosphatase E, transcript variant X2
inositol polyphosphate-5-phosphatase E, transcript variant X3
72 kDa inositol polyphosphate 5-phosphatase isoform X1
72 kDa inositol polyphosphate 5-phosphatase isoform X2
peptidase, mitochondrial processing alpha subunit
mitochondrial-processing peptidase subunit alpha
serologically defined colon cancer antigen 3
small nuclear RNA activating complex polypeptide 4
snRNA-activating protein complex subunit 4
caspase recruitment domain family member 9, transcript variant X2
caspase recruitment domain family member 9, transcript variant X5
caspase recruitment domain family member 9, transcript variant X4
caspase recruitment domain family member 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
caspase recruitment domain family member 9, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
caspase recruitment domain family member 9, transcript variant X8
caspase recruitment domain family member 9, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
caspase recruitment domain family member 9, transcript variant X3
caspase recruitment domain family member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
caspase recruitment domain-containing protein 9 isoform X2
caspase recruitment domain-containing protein 9 isoform X4
caspase recruitment domain-containing protein 9 isoform X1
caspase recruitment domain-containing protein 9 isoform X3
caspase recruitment domain-containing protein 9 isoform X5
DNL-type zinc finger, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01009254.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 312 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
DNL-type zinc finger, transcript variant X3
DNL-type zinc finger, transcript variant X6
DNL-type zinc finger, transcript variant X4
DNL-type zinc finger, transcript variant X7
DNL-type zinc finger, transcript variant X2
DNL-type zinc finger, transcript variant X5
DNL-type zinc finger, transcript variant X8
DNL-type zinc finger, transcript variant X9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 312 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
DNL-type zinc finger, transcript variant X10
DNL-type zinc finger, transcript variant X11
DNL-type zinc finger, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DNL-type zinc finger, transcript variant X13
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 312 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DNL-type zinc finger, transcript variant X14
DNL-type zinc finger, transcript variant X15
DNL-type zinc finger, transcript variant X16
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 312 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 294 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
G protein signaling modulator 1, transcript variant X2
G protein signaling modulator 1, transcript variant X1
G protein signaling modulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X10
G protein signaling modulator 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X11
G protein signaling modulator 1, transcript variant X6
G protein signaling modulator 1, transcript variant X12
G protein signaling modulator 1, transcript variant X8
G protein signaling modulator 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
G-protein-signaling modulator 1 isoform X2
G-protein-signaling modulator 1 isoform X1
G-protein-signaling modulator 1 isoform X4
G-protein-signaling modulator 1 isoform X5
G-protein-signaling modulator 1 isoform X6
G protein signaling modulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
G-protein-signaling modulator 1 isoform X3
coiled-coil domain containing 187, transcript variant X2
coiled-coil domain containing 187, transcript variant X1
coiled-coil domain containing 187, transcript variant X4
coiled-coil domain containing 187, transcript variant X3
coiled-coil domain containing 187, transcript variant X5
coiled-coil domain containing 187, transcript variant X7
coiled-coil domain containing 187, transcript variant X6
coiled-coil domain-containing protein 187 isoform X1
coiled-coil domain-containing protein 187 isoform X3
coiled-coil domain-containing protein 187 isoform X2
coiled-coil domain-containing protein 187 isoform X4
coiled-coil domain-containing protein 187 isoform X6
coiled-coil domain-containing protein 187 isoform X5
coiled-coil domain containing 187, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
coiled-coil domain-containing protein 187 isoform X7
quiescin sulfhydryl oxidase 2, transcript variant X1
similar to RNA sequence (same species):INSD:GBYG01018101.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 75 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
quiescin sulfhydryl oxidase 2, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 75 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 61 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 250, transcript variant X1
transmembrane protein 250, transcript variant X6
transmembrane protein 250, transcript variant X2
transmembrane protein 250, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 250, transcript variant X4
transmembrane protein 250, transcript variant X3
NACC family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NACC family member 2, transcript variant X1
NACC family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
NACC family member 2, transcript variant X5
NACC family member 2, transcript variant X3
NACC family member 2, transcript variant X4
nucleus accumbens-associated protein 2 isoform X1
nucleus accumbens-associated protein 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC110406998
UBA domain containing 1, transcript variant X1
UBA domain containing 1, transcript variant X2
ubiquitin-associated domain-containing protein 1 isoform X1
ubiquitin-associated domain-containing protein 1 isoform X2
calmodulin regulated spectrin associated protein 1, transcript variant X1
calmodulin-regulated spectrin-associated protein 1 isoform X1
calmodulin regulated spectrin associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
calmodulin-regulated spectrin-associated protein 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC110406946
putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC100288842
26S proteasome non-ATPase regulatory subunit 5
cutA divalent cation tolerance homolog, transcript variant X2
cutA divalent cation tolerance homolog, transcript variant X1
PHD finger protein 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PHD finger protein 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
PHD finger protein 19, transcript variant X2
TNF receptor associated factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TNF receptor associated factor 1, transcript variant X1
TNF receptor associated factor 1, transcript variant X2
TNF receptor-associated factor 1 isoform X2
TNF receptor-associated factor 1 isoform X1
TNF receptor-associated factor 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
erythrocyte band 7 integral membrane protein
DAB2 interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
disabled homolog 2-interacting protein isoform X3
disabled homolog 2-interacting protein isoform X1
disabled homolog 2-interacting protein isoform X2
DAB2 interacting protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X6
DAB2 interacting protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
disabled homolog 2-interacting protein isoform X4
DAB2 interacting protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
disabled homolog 2-interacting protein isoform X5
DAB2 interacting protein, transcript variant X9
disabled homolog 2-interacting protein isoform X6
tubulin tyrosine ligase like 11, transcript variant X7
tubulin tyrosine ligase like 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
tubulin tyrosine ligase like 11, transcript variant X5
tubulin tyrosine ligase like 11, transcript variant X8
tubulin tyrosine ligase like 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
tubulin tyrosine ligase like 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tubulin tyrosine ligase like 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tubulin tyrosine ligase like 11, transcript variant X1
tubulin polyglutamylase TTLL11 isoform X1
tubulin tyrosine ligase like 11, transcript variant X9
tubulin polyglutamylase TTLL11 isoform X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like isoform X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like isoform X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like isoform X3
NADH:ubiquinone oxidoreductase subunit A8
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8
MORN repeat containing 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
MORN repeat containing 5, transcript variant X2
MORN repeat containing 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
MORN repeat containing 5, transcript variant X1
MORN repeat containing 5, transcript variant X5
MORN repeat-containing protein 5 isoform X1
MORN repeat-containing protein 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
mitochondrial ribosome recycling factor, transcript variant X2
mitochondrial ribosome recycling factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
mitochondrial ribosome recycling factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitochondrial ribosome recycling factor, transcript variant X5
ribosome-recycling factor, mitochondrial isoform X4
mitochondrial ribosome recycling factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ribosome-recycling factor, mitochondrial isoform X2
ribosome-recycling factor, mitochondrial isoform X3
ribosome-recycling factor, mitochondrial isoform X1
similar to RNA sequence (same species):INSD:GBYG01032448.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 60 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 13 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
ring finger and CCCH-type domains 2, transcript variant X3
ring finger and CCCH-type domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ring finger and CCCH-type domains 2, transcript variant X1
ring finger and CCCH-type domains 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 6
zinc finger and BTB domain containing 26
zinc finger and BTB domain-containing protein 26
RAB GTPase activating protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X7
spermatid perinuclear RNA binding protein, transcript variant X6
spermatid perinuclear RNA-binding protein isoform X3
spermatid perinuclear RNA binding protein, transcript variant X3
spermatid perinuclear RNA binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X1
spermatid perinuclear RNA binding protein, transcript variant X2
spermatid perinuclear RNA binding protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
spermatid perinuclear RNA-binding protein isoform X2
spermatid perinuclear RNA-binding protein isoform X1
spermatid perinuclear RNA-binding protein isoform X4
crumbs 2, cell polarity complex component, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
crumbs 2, cell polarity complex component, transcript variant X8
crumbs 2, cell polarity complex component, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
crumbs 2, cell polarity complex component, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
crumbs 2, cell polarity complex component, transcript variant X9
crumbs 2, cell polarity complex component, transcript variant X3
crumbs 2, cell polarity complex component, transcript variant X1
crumbs 2, cell polarity complex component, transcript variant X5
crumbs 2, cell polarity complex component, transcript variant X14
crumbs 2, cell polarity complex component, transcript variant X2
crumbs 2, cell polarity complex component, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
crumbs 2, cell polarity complex component, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
crumbs 2, cell polarity complex component, transcript variant X11
crumbs 2, cell polarity complex component, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DENN domain containing 1A, transcript variant X2
DENN domain containing 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DENN domain containing 1A, transcript variant X3
DENN domain containing 1A, transcript variant X5
DENN domain containing 1A, transcript variant X4
DENN domain containing 1A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DENN domain-containing protein 1A isoform X3
DENN domain-containing protein 1A isoform X2
DENN domain-containing protein 1A isoform X1
DENN domain-containing protein 1A isoform X4
DENN domain-containing protein 1A isoform X5
DENN domain-containing protein 1A isoform X6
DENN domain containing 1A, transcript variant X7
DENN domain-containing protein 1A isoform X7
NIMA related kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
NIMA related kinase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
NIMA related kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase Nek6 isoform X1
serine/threonine-protein kinase Nek6 isoform X2
adhesion G protein-coupled receptor D2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor D2, transcript variant X3
adhesion G protein-coupled receptor D2, transcript variant X1
adhesion G protein-coupled receptor D2, transcript variant X5
adhesion G protein-coupled receptor D2, transcript variant X4
adhesion G protein-coupled receptor D2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G-protein coupled receptor D2 isoform X5
adhesion G-protein coupled receptor D2 isoform X4
adhesion G-protein coupled receptor D2 isoform X1
adhesion G-protein coupled receptor D2 isoform X3
adhesion G-protein coupled receptor D2 isoform X2
uncharacterized LOC110406828, transcript variant X2
uncharacterized LOC110406828, transcript variant X1
uncharacterized LOC110406828, transcript variant X3
nuclear receptor subfamily 5 group A member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 5 group A member 1, transcript variant X2
nuclear receptor subfamily 6 group A member 1
similar to RNA sequence (same species):INSD:GBYG01038493.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 52 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 28 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01031011.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 83 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01001607.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 78 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01033651.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 90 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 90 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
actin related protein 2/3 complex subunit 5 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
actin-related protein 2/3 complex subunit 5-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 catalytic subunit
Rab9 effector protein with kelch motifs, transcript variant X1
Rab9 effector protein with kelch motifs, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
rab9 effector protein with kelch motifs isoform X1
rab9 effector protein with kelch motifs isoform X2
heat shock protein family A (Hsp70) member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110406907, transcript variant X1
uncharacterized protein LOC110406907 isoform X1
uncharacterized LOC110406907, transcript variant X2
uncharacterized protein LOC110406907 isoform X2
GTPase activating protein and VPS9 domains 1, transcript variant X6
GTPase activating protein and VPS9 domains 1, transcript variant X4
GTPase activating protein and VPS9 domains 1, transcript variant X8
GTPase activating protein and VPS9 domains 1, transcript variant X9
GTPase activating protein and VPS9 domains 1, transcript variant X3
GTPase activating protein and VPS9 domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X2
GTPase activating protein and VPS9 domains 1, transcript variant X10
GTPase activating protein and VPS9 domains 1, transcript variant X5
GTPase activating protein and VPS9 domains 1, transcript variant X7
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X1
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X2
mitogen-activated protein kinase associated protein 1, transcript variant X2
mitogen-activated protein kinase associated protein 1, transcript variant X1
target of rapamycin complex 2 subunit MAPKAP1 isoform X2
target of rapamycin complex 2 subunit MAPKAP1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X1
pre-B-cell leukemia transcription factor 3 isoform X3
pre-B-cell leukemia transcription factor 3 isoform X4
pre-B-cell leukemia transcription factor 3 isoform X6
pre-B-cell leukemia transcription factor 3 isoform X5
pre-B-cell leukemia transcription factor 3 isoform X2
uncharacterized LOC110406942, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC110406942, transcript variant X3
uncharacterized LOC110406942, transcript variant X1
multivesicular body subunit 12B, transcript variant X4
multivesicular body subunit 12B, transcript variant X1
multivesicular body subunit 12B, transcript variant X2
multivesicular body subunit 12B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger and BTB domain containing 43
zinc finger and BTB domain-containing protein 43
zinc finger and BTB domain containing 34, transcript variant X1
zinc finger and BTB domain containing 34, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 34
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X1
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X2
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X3
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X6
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X2
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X1
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X4
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X3
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X5
F-box and WD repeat domain containing 2, transcript variant X3
F-box and WD repeat domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
F-box and WD repeat domain containing 2, transcript variant X1
solute carrier family 2 member 8, transcript variant X1
solute carrier family 2 member 8, transcript variant X2
solute carrier family 2 member 8, transcript variant X3
solute carrier family 2 member 8, transcript variant X4
solute carrier family 2 member 8, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 8 isoform X1
solute carrier family 2, facilitated glucose transporter member 8 isoform X2
solute carrier family 2, facilitated glucose transporter member 8 isoform X3
solute carrier family 2, facilitated glucose transporter member 8 isoform X4
GTPase activating Rap/RanGAP domain like 3, transcript variant X7
GTPase activating Rap/RanGAP domain like 3, transcript variant X4
GTPase activating Rap/RanGAP domain like 3, transcript variant X3
GTPase activating Rap/RanGAP domain like 3, transcript variant X2
GTPase activating Rap/RanGAP domain like 3, transcript variant X6
GTPase activating Rap/RanGAP domain like 3, transcript variant X1
GTPase activating Rap/RanGAP domain like 3, transcript variant X5
GTPase activating Rap/RanGAP domain like 3, transcript variant X8
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X4
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X3
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X2
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X6
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X1
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X5
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X7
GTPase activating Rap/RanGAP domain like 3, transcript variant X9
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X8
uncharacterized LOC110406892, transcript variant X3
uncharacterized LOC110406892, transcript variant X1
uncharacterized LOC110406892, transcript variant X2